Stonnington Group LLC Raises Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Stonnington Group LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 7.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,583 shares of the healthcare conglomerate’s stock after acquiring an additional 1,985 shares during the quarter. UnitedHealth Group comprises approximately 3.5% of Stonnington Group LLC’s holdings, making the stock its 3rd biggest position. Stonnington Group LLC’s holdings in UnitedHealth Group were worth $14,824,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. MCIA Inc increased its holdings in UnitedHealth Group by 1.3% in the 1st quarter. MCIA Inc now owns 3,786 shares of the healthcare conglomerate’s stock worth $2,035,000 after acquiring an additional 50 shares in the last quarter. RDA Financial Network increased its holdings in UnitedHealth Group by 9.3% in the 1st quarter. RDA Financial Network now owns 8,886 shares of the healthcare conglomerate’s stock worth $4,532,000 after acquiring an additional 759 shares in the last quarter. Wedge Capital Management L L P NC increased its holdings in UnitedHealth Group by 0.5% in the 1st quarter. Wedge Capital Management L L P NC now owns 17,008 shares of the healthcare conglomerate’s stock worth $8,674,000 after acquiring an additional 83 shares in the last quarter. Matisse Capital increased its holdings in UnitedHealth Group by 24.0% in the 1st quarter. Matisse Capital now owns 930 shares of the healthcare conglomerate’s stock worth $474,000 after acquiring an additional 180 shares in the last quarter. Finally, First Affirmative Financial Network grew its holdings in UnitedHealth Group by 12.5% during the 1st quarter. First Affirmative Financial Network now owns 2,172 shares of the healthcare conglomerate’s stock valued at $1,108,000 after buying an additional 241 shares in the last quarter. 87.48% of the stock is owned by institutional investors.

In related news, Director Frederick William Mcnabb III bought 89 shares of the business’s stock in a transaction on Thursday, May 26th. The shares were bought at an average price of $504.32 per share, for a total transaction of $44,884.48. Following the completion of the purchase, the director now directly owns 11,259 shares of the company’s stock, valued at $5,678,138.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction dated Monday, May 16th. The shares were sold at an average price of $493.25, for a total value of $1,233,125.00. Following the completion of the transaction, the director now owns 1,220,000 shares in the company, valued at approximately $601,765,000. The disclosure for this sale can be found here. Company insiders own 0.40% of the company’s stock.

NYSE:UNH opened at $489.68 on Thursday. UnitedHealth Group Incorporated has a twelve month low of $383.12 and a twelve month high of $553.29. The company has a market cap of $459.40 billion, a price-to-earnings ratio of 26.80, a price-to-earnings-growth ratio of 1.41 and a beta of 0.83. The stock has a fifty day simple moving average of $496.56 and a 200-day simple moving average of $490.86. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.54.

UnitedHealth Group (NYSE:UNHGet Rating) last released its earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share for the quarter, topping the consensus estimate of $5.40 by $0.09. The business had revenue of $80.15 billion during the quarter, compared to the consensus estimate of $78.77 billion. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The business’s revenue for the quarter was up 14.2% compared to the same quarter last year. During the same period last year, the company earned $5.31 earnings per share. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 21.75 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 28th. Stockholders of record on Monday, June 20th will be paid a dividend of $1.65 per share. The ex-dividend date of this dividend is Thursday, June 16th. This represents a $6.60 annualized dividend and a dividend yield of 1.35%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.45. UnitedHealth Group’s dividend payout ratio (DPR) is currently 36.12%.

A number of brokerages have issued reports on UNH. Raymond James increased their price objective on shares of UnitedHealth Group from $540.00 to $620.00 and gave the company a “strong-buy” rating in a report on Tuesday, April 19th. Credit Suisse Group increased their price objective on shares of UnitedHealth Group from $564.00 to $595.00 and gave the company an “outperform” rating in a report on Monday, April 18th. Barclays increased their price objective on shares of UnitedHealth Group from $495.00 to $565.00 and gave the company an “overweight” rating in a report on Wednesday, March 30th. Morgan Stanley increased their target price on UnitedHealth Group from $570.00 to $577.00 and gave the company an “overweight” rating in a research report on Monday, April 18th. Finally, StockNews.com started coverage on UnitedHealth Group in a research report on Thursday, March 31st. They set a “strong-buy” rating for the company. Three analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $555.73.

About UnitedHealth Group (Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.